Cancer treatment and pharmacogenetics of cytochrome P450 enzymes

Author： Schaik Ron  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.23, Iss.6, 2005-12, pp. : 513-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction of cytochrome P450 enzymes by albendazole treatment in the rat

By Asteinza J.   Camacho-Carranza R.   Reyes-Reyes R.E.   Dorado-Gonzalez V.   Espinosa-Aguirre J.J.  

Environmental Toxicology and Pharmacology, Vol. 9, Iss. 1, 2000-12 ,pp. : 31-37

Elsevier

Access to resources Recommend Favorite

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

By Ingelman-Sundberg M.   Oscarson M.   McLellan R.A.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. : 342-349

Elsevier

Access to resources Recommend Favorite

Cytochrome P450 pharmacogenetics in African populations

By Alessandrini Marco   Asfaha Sahle   Dodgen Tyren Mark   Warnich Louise   Pepper Michael Sean  

Drug Metabolism Reviews, Vol. 45, Iss. 2, 2013-05 ,pp. : 253-275

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome p450 enzymes and cardiovascular disease

By Hunter Arwen L   Cruz Rani P   Cheyne Bo M   McManus Bruce M   Granville David J  

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 12, 2004-12 ,pp. : 1053-1060

NRC Research Press

Access to resources Recommend Favorite

Effects of icaritin on cytochrome P450 enzymes in rats

By Liang Dong-Lou   Zheng Shuang-Li  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 4, 2014-04 ,pp. : 301-305

Govi-Verlag

Access to resources Recommend Favorite